DEVELOPMENT ASSESSMENT PANEL (DAP) LOCAL GOVERNMENT MEMBERS Metro West JDAP Local Member Local Member

Source URL: daps.planning.wa.gov.au

1223 Final decision analytic protocol (DAP) to guide the assessment of the insertion, replacement or removal of a cardiac resynchronisation therapy device capable of defibrillation (CRT-D) for mild chronic heart failure

Source URL: www.msac.gov.au

• Circulatory system
• Biology
• Implants
• Neuroprosthetics
• Medical emergencies
• Artificial cardiac pacemaker
• Implantable cardioverter-defibrillator
• Heart failure
• Ventricular tachycardia
• Medicine
• Cardiac electrophysiology
• Cardiac dysrhythmia

DEVELOPMENT ASSESSMENT PANEL (DAP) LOCAL GOVERNMENT MEMBERS Peel JDAP Local Member Local Member

Source URL: daps.planning.wa.gov.au

1250 Consultation Decision Analytic Protocol (DAP) to guide the assessment of diagnostic testing for Anaplastic Lymphoma Kinase (ALK) gene rearrangement in patients with advanced non-small cell lung cancer to determine e

Source URL: www.msac.gov.au

• Lung cancer
• Organofluorides
• Organochlorides
• Pfizer
• Quinazolines
• Crizotinib
• Non-small-cell lung carcinoma
• Anaplastic lymphoma kinase
• Protein kinase inhibitor
• Medicine
• Chemistry
• Oncology

MSAC Application 1207: Consultation Decision Analytical Protocol (DAP) to guide the assessment of BRAF genetic testing in patients with melanoma for access to proposed PBS-funded GSK2118436 treatment January 2012

Source URL: www.msac.gov.au

• Vemurafenib
• Cancer
• Metastasis
• Protein kinase inhibitor
• Medicine
• Melanoma
• BRAF

1293 Consultation Decision Analytic Protocol (DAP) to guide the assessment of Epidermal Growth Factor Receptor (EGFR) gene mutation testing for eligibility for afatinib treatment in patients with stage IIIB or stage IV

Source URL: www.msac.gov.au

• Quinazolines
• Tyrosine kinase receptors
• Organofluorides
• Amines
• Organochlorides
• Gefitinib
• Erlotinib
• Epidermal growth factor receptor
• Afatinib
• Chemistry
• Organic chemistry
• Medicine

MSAC Application 1174: Consultation Decision Analytic Protocol (DAP) to guide the assessment of a pathology test to determine if a patient has been infected with CCR5 tropic

Source URL: www.msac.gov.au

• Immune system
• Maraviroc
• Trofile assay
• CCR5
• Monogram Biosciences
• HIV tropism
• HIV
• Antiretroviral drug
• AIDS
• HIV/AIDS
• Biology
• Chemistry

Application 1192: Consultation Decision Analytic Protocol (DAP) to guide the assessment of reduction of mitral regurgitation through tissue approximation using transvenous/ transseptal techniques

Source URL: www.msac.gov.au

• Valvular heart disease
• Circulatory system
• Mitral valve replacement
• Mitral valve repair
• Mitral regurgitation
• Mitral valve
• Heart valve repair
• Mitral stenosis
• Heart valve
• Medicine
• Cardiac surgery
• Cardiology

1293 Final Decision Analytic Protocol (DAP) to guide the assessment of Epidermal Growth Factor Receptor (EGFR) gene mutation testing for eligibility for afatinib treatment in patients with stage IIIB or stage IV non-sma

Source URL: www.msac.gov.au

• Quinazolines
• Organofluorides
• Amines
• Organochlorides
• Lung cancer
• Gefitinib
• Erlotinib
• Epidermal growth factor receptor
• Afatinib
• Chemistry
• Organic chemistry
• Medicine

1310 Consultation Decision Analytic Protocol (DAP) to guide the assessment of optical coherence tomography for assessment of central retinal thickness in the presence of macular oedema secondary to central retinal vein o

Source URL: www.msac.gov.au

• Blindness
• Macular edema
• Central retinal vein occlusion
• Electroretinography
• Glaucoma
• Diabetic retinopathy
• Macular degeneration
• Ranibizumab
• Bevacizumab
• Medicine
• Ophthalmology
• Health